The Next Big Thing In Biotech: ASH Meeting
Dec 07, 2012 | 6:00 AM EST - 
Adam Feuerstein, Sr. Columnist for TheStreet, says the American Society of Hematology meeting is the next big thing to watch in biotech.

Columnist Conversations

There has been a consistent pattern from the oil markets in the past year. OPEC makes noise about constraining...
yesterday we rolled up a prior play and added an at the money on this momentum name. BOUGHT GWPH NOV 125 CA...
yesterday we added some WDC calls (sorry it's late, i'm still in Chicago and had some internet connection issu...
Markets having a nice day as evidently investors believe Hillary Clinton held her own in the debate last night...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.